The ability to deal with the complexity of the clinical supply process has shifted the balance of power to clinical supply chain specialists.
Apr 1, 2010
By:
Jim Miller
The ability to deal with the complexity of the clinical supply process has shifted the balance of power to clinical supply chain specialists.
|
As facility closures and layoffs continue, CRO and CMO executives are hoping for a better year, despite few positive signs.
Feb 1, 2010
By:
Jim Miller
As facility closures and layoffs continue, CRO and CMO executives are hoping for a better year, despite few positive signs.
|
A new analysis highlights growth opportunities and challenges for contract development and manufacturing organizations.
Dec 1, 2009
By:
Jim Miller
A new analysis highlights growth opportunities and challenges for contract development and manufacturing organizations.
|
Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.
Oct 1, 2009
By:
Jim Miller
Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.
|
Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.
Aug 1, 2009
By:
Jim Miller
Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.
|
UK-based CMOs seek opportunities in new markets.
Jun 1, 2009
By:
Jim Miller
UK-based CMOs seek opportunities in new markets.
|
The current competitive environment is forcing service providers to evaluate their business models and focus on value and performance.
May 1, 2009
By:
Jim Miller
The current competitive environment is forcing service providers to evaluate their business models and focus on value and performance.
|
As financing for early-stage companies gets tighter, small CROs will find fewer new business opportunities
Feb 1, 2009
By:
Jim Miller
What the current lack of venture capital means for the CRO market.
|
The outlook for cell culture capacity is highly variable, but contract manufacturing capacity could be tight.
Nov 1, 2008
By:
Jim Miller
There could be a serious glut of commercial scale mammalian cell culture capacity over the next five years. Then again, there could be a significant shortage. It all depends on how things develop in expression technology, the new product pipeline, and corporate strategies.
|
|
